Stocks higher on vaccine optimism - Monday Review, March 1

Stocks higher on vaccine optimism - Monday Review, March 1

European and Asian manufacturing data impressed investors

The US

The stocks closed higher, driven by positive vaccine news and stimulus progress. USA30 added 2.1%, and USA500 was up 2.6%. TECH100 jumped 2.9%.

Crude oil traded at $62.66 per barrel after it went up 1.9%.

Gold settled at $1,723 per ounce after it lost 0.3%, marking the fifth consecutive session loss.

Asia and Australia

HongKong45 gained 0.72% as investors were awaiting the outcome of the Hang Seng Indexes Co. industry meeting over the proposed changes to the index.

Japan225 jumped 2.19% after the manufacturing PMI reading of 51.4 in February came above the 50.6 forecasted.

Down under, Australia200 rose 1.15% as the Reserve Bank is due to hand down its monetary policy on Tuesday.

Europe

Germany30 traded 1.1% higher. France40 rose 1.5%, and UK100 climbed 1.7%. The PMI data came in higher than forecasted at 57.9 in February from a previous 54.8.

Brent oil rose 1.9% to $65.63 per barrel.

EUR/USD traded at 1.2051 after it lost 0.2%.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.